Exelixis (EXEL) Net Equity Issued and Repurchased (2011 - 2016)
Exelixis' (EXEL) quarterly Net Equity Issued and Repurchased came in at $37000.0 in Q1 2016, down 99.97% quarter-over-quarter from $145.7 million in Q3 2015.
Exelixis (EXEL) Net Equity Issued and Repurchased (2011 - 2016) Analysis & Trends
Exelixis' Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at $37000.0 for Q1 2016.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $37000.0 in Q1 2016; TTM through Mar 2016 was $145.7 million, a 4856366.67% increase from a year earlier, with the FY2015 full-year figure at $145.6 million, up 92.55% from the prior year.
- Net Equity Issued and Repurchased declined to $37000.0 in Q1 2016 per EXEL's latest filing, from $145.7 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $145.7 million in Q3 2015 and bottomed at -$3000.0 in Q4 2014.
- The 4-year median for Net Equity Issued and Repurchased is $32.5 million (2012), against an average of $47.7 million.
- Biggest YoY gain for Net Equity Issued and Repurchased was 300.0% in 2012; the steepest drop was 63.77% in 2012.
- Year by year, Net Equity Issued and Repurchased stood at $46000.0 in 2012, then plunged by 106.52% to -$3000.0 in 2014, then soared by 4855133.33% to $145.7 million in 2015, then tumbled by 99.97% to $37000.0 in 2016.
- Per Business Quant, the three latest EXEL Net Equity Issued and Repurchased figures stand at $37000.0 (Q1 2016), $145.7 million (Q3 2015), and -$3000.0 (Q4 2014).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 37,000.00 |
| Mar 31, 2016 | 37,000.00 |
| Sep 30, 2015 | 145.65 Mn |
| Sep 30, 2015 | 145.65 Mn |
| Dec 31, 2014 | -3,000.00 |
| Dec 31, 2014 | -3,000.00 |
| Mar 31, 2014 | 75.65 Mn |
| Mar 31, 2014 | 75.65 Mn |
| Jun 30, 2012 | 46,000.00 |
| Jun 30, 2012 | 46,000.00 |
| Mar 31, 2012 | 64.99 Mn |
| Mar 31, 2012 | 64.99 Mn |
| Dec 31, 2011 | -2,000.00 |
| Dec 31, 2011 | -2,000.00 |
| Jun 30, 2011 | -23,000.00 |
| Jun 30, 2011 | -23,000.00 |
| Mar 31, 2011 | 179.40 Mn |
| Mar 31, 2011 | 179.40 Mn |